Products of metabolic activation of the antitumor drug ledakrin (Nitracrine) in vitro

Chemical Research in Toxicology

Volumn 14, Issue 1, 2001, Pages 1-10

  Gorlewska, Katarzyna ^a   Mazerska, Zofia ^a   Sowiński, Paweł ^a   Konopa, Jerzy ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOACRIDINONE; ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; DITHIOTHREITOL; HYDRAZINE; NITRACRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TIN CHLORIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; DRUG ACTIVATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DITHIOTHREITOL; HYDRAZINES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICROSOMES, LIVER; NAD(P)H DEHYDROGENASE (QUINONE); NITRACRINE; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REDUCING AGENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIN COMPOUNDS; XANTHINE OXIDASE;

EID: 0035148495     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000081c     Document Type: Article

References (13)

1. 9-derivatives of 1-, 2-, 3-, and 4-nitro-9-aminoacridine. Rocz. Chem. 40, 301-307.
2. WHO Chronicle (1976) Vol. 30 (Suppl. 3), p 11, World Health Organization, Geneva.
3. Kwaśniewska-Rokicimska, C., Sawicki, J., and Drosik, K. (1976) Preliminary observations of the ledakrin effect in treatment of patients with lung carcinoma. Mater. Med. Pol. (Engl. Ed.) 8, 289-294.
4. Bratkowska-Seniów, B., Oleszkiewicz, L., Kozak, E., and Krizar, T. (1976) Ledakrin in treatment of colon carcinoma. Mater. Med. Pol. (Engl. Ed.) 8, 323-330.
5. Konopa, J., Ledóchowski, A., Matuszkiewicz, A., and Jereczek-Morawska, E. (1969) In vitro studies on the cytotoxic properties of 9-aminoacridine derivatives. Neoplasma 16, 171-179.
6. Hrabowska, M., Mazerska, Z., Paradziej-Łukowicz, J., Onoszko, K., and Ledóchowski, A. (1982) Antitumor activity of 1-nitro-9-aminoacridine derivatives. Arzneim.-Forsch. 32, 1013-1016.
7. Mazerska, Z., and Ledóchowski, A. (1984) QSAR of acridines. I. Search for antitumor derivatives of 1-nitro-9-(3′-aminopropylamino)acridine. Eur. J. Med. Chem. 19, 199-204.
8. Mazerska, Z., Łukowicz, J., and Konopa, J. (1990) Antitumor activity of 1-nitro-9-aminoacridine derivatives, including Nitracrine, against some ascitic experimental tumors. Arzneim.-Forsch. 40, 472-477.
9. Mazerska, Z., Mazerski, J., and Ledóchowski, A. (1990) QSAR of acridines. II. Features of Nitracrine analogs for high antitumor activity and selectivity on mice, searched by PCA and MRA methods. Anti-Cancer Drug Des. 5, 169-187.
10. 14C-(3′-dimethylamino-N-propylamino)acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells. Biochem. Pharmacol. 28, 3391-3402.
11. Pawlak, J. W., Pawlak, K., and Konopa, J. (1983) The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vitro enzyme mediated covalent binding of a 1-nitroacridine derivative Ledakrin or Nitracrine with DNA and other macromolecules of mammalian or bacterial cells. Chem.-Biol. Interact. 43, 151-173.
12. Szmigiero, L., and Studzian, K (1989) DNA damage and cytotoxicity of nitracrine in cultured HeLa cells. Biochim. Biophys. Acta 1008, 339-345.
13. 32P-post-labeling analysis of DNA adduct formation by antitumor drug Nitracrine (Ledakrin) and other nitroacridines in different biological systems. Biochem. Pharmacol. 38, 1301-1312.